Alzheimer’s is Beaten: Bredesen RCT Proves Personalized Medicine is the Answer

The February 2026 issue of IHCAN Magazine, the UK’s leading publication for integrative healthcare professionals, highlights an in-depth interview with Dr. Dale Bredesen and the study physicians discussing the clinical implications of the randomized controlled trial preprint.

The article explores patient outcomes, real-world clinical insights, biomarker findings, and what the results mean for the future of personalized Alzheimer’s care under the ReCODE Protocol™.

IHCAN Magazine is offering a special discounted print subscription + a free issue for new subscribers HERE. You may subscribe to a digital-only subscription HERE. (Note: additional postage fees may apply for print subscribers outside of the UK.) 

Learn more about the 2025 randomized controlled trial and download a PDF of the article HERE.